# Becoya

Generated by Yoast SEO v27.8, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Get In Touch](https://becoya.com/get-in-touch/)
- [Pulse](https://becoya.com/tools/pulse/)
- [Tools](https://becoya.com/tools/)
- [The Local Lens](https://becoya.com/the-local-lens/)
- [Product Value \& Pricing Strategy](https://becoya.com/offerings/value-and-access/product-value-and-pricing-strategy/)

## Posts
- [test](https://becoya.com/test/)

## Case Studies
- [Conducting a Market Research Study to Understand the Cost Implication and Potential Benefits of the Introduction of an IPV\-containing Hexavalent Vaccine to the Childhood Vaccine Schedule](https://becoya.com/case-studies/conducting-a-market-research-study-to-understand-the-cost-implication-and-potential-benefits-of-the-introduction-of-an-ipv-containing-hexavalent-vaccine-to-the-childhood-vaccine-schedule/)
- [Mitigating compliance risk and enhancing commercial capabilities across a multi\-market distributor network](https://becoya.com/case-studies/mitigating-compliance-risk-and-enhancing-commercial-capabilities-across-a-multi-market-distributor-network/)
- [Data\-driven distributor selection for a specialized oncology portfolio market entry](https://becoya.com/case-studies/data-driven-distributor-selection-for-a-specialized-oncology-portfolio-market-entry/)
- [Using local hospital data to prevent a mandatory price cut for a cardiovascular drug](https://becoya.com/case-studies/using-local-hospital-data-to-prevent-a-mandatory-price-cut-for-a-cardiovascular-drug/)
- [Cost\-minimization analysis to optimize net price strategy for an oncology biologic in KSA](https://becoya.com/case-studies/cost-minimization-analysis-to-optimize-net-price-strategy-for-an-oncology-biologic-in-ksa/)

## Events
- [World Orphan Drug Congress, Amsterdam](https://becoya.com/events/world-orphan-drug-congress-amsterdam/)

## Industry Perspectives
- [Strategic Defense against Generic Entry for Rare Disease Products in KSA](https://becoya.com/the-local-lens/industry-perspective/strategic-defense-against-generic-entry-for-rare-disease-products-in-ksa/)

## Market Snapshots
- [Market Snapshot: United Arab Emirates](https://becoya.com/the-local-lens/market-snapshots/market-snapshot-united-arab-emirates/)
- [Market Snapshot: Turkiye](https://becoya.com/market-snapshots/market-snapshot-turkiye/)
- [Market Snapshot: Qatar](https://becoya.com/market-snapshots/market-snapshot-qatar/)
- [Market Snapshot: Saudi Arabia](https://becoya.com/market-snapshots/market-snapshot-saudi-arabia/)
- [Market Snapshot: Bahrain](https://becoya.com/market-snapshots/market-snapshot-bahrain/)

## Viewpoints
- [Named Patient Supply \(NPS\) in the GCC](https://becoya.com/the-local-lens/viewpoints/named-patient-supply-nps-in-the-gcc/)
- [Changing global assessments \- The MENA opportunity amidst the global challenges](https://becoya.com/the-local-lens/viewpoints/changing-global-assessments-the-mena-opportunity-amidst-the-global-challenges/)
- [Evolving role of HTA in the UAE](https://becoya.com/the-local-lens/viewpoints/evolving-role-of-hta-in-the-uae/)
- [The Enduring Burden of Malaria in Africa](https://becoya.com/the-local-lens/viewpoints/the-enduring-burden-of-malaria-in-africa/)
- [Importance of Local Clinical Data in the Kingdom of Saudi Arabia](https://becoya.com/the-local-lens/viewpoints/importance-of-local-clinical-data-in-the-kingdom-of-saudi-arabia/)

## White Paper
- [Look Beyond the US and Europe: Discover the Untapped Potential of the Rare Disease Market in the Middle East](https://becoya.com/white-paper/discover-the-untapped-potential-of-the-rare-disease-market-in-the-middle-east/)
- [ATMPs: Critical Success Drivers for the Achievement of Premium Pricing in Saudi Arabia](https://becoya.com/white-paper/atmps-critical-success-drivers-for-the-achievement-of-premium-pricing-in-saudi-arabia/)
- [The Localization Imperative: Navigating the New Localization Requirements in Saudi Arabia](https://becoya.com/white-paper/the-localization-imperative-navigating-the-new-localization-requirements-in-saudi-arabia/)
- [Perception of Value of Breakthrough Designation in Saudi Arabia](https://becoya.com/white-paper/perception-of-value-of-breakthrough-designation-in-saudi-arabia/)
- [Rare Disease Funding: A Spotlight on Saudi Arabia](https://becoya.com/white-paper/rare-disease-funding-a-spotlight-on-saudi-arabia-2/)

## Categories
- [Value \& Access](https://becoya.com/category/value-access/)
- [Insights](https://becoya.com/category/insights/)
- [Health Economics](https://becoya.com/category/health-economics/)
- [Alliance](https://becoya.com/category/alliance/)

## Countries
- [KSA](https://becoya.com/countries/ksa/)
- [UAE](https://becoya.com/countries/uae/)
- [Qatar](https://becoya.com/countries/qatar/)
- [Kuwait](https://becoya.com/countries/kuwait/)
- [Egypt](https://becoya.com/countries/egypt/)

## resources
- [Viewpoints](https://becoya.com/resource/viewpoints/)
- [White Paper](https://becoya.com/resource/white-paper/)
- [Industry Perspectives](https://becoya.com/resource/industry-perspectives/)
- [Market Snapshots](https://becoya.com/resource/market-snapshots/)
- [Digital Guides](https://becoya.com/resource/digital-guides/)

## Years
- [2020](https://becoya.com/years/2020/)
- [2024](https://becoya.com/years/2024/)
- [2022](https://becoya.com/years/2022/)
- [2021](https://becoya.com/years/2021/)
- [2015](https://becoya.com/years/2015/)

## Optional
- [Sitemap index](https://becoya.com/sitemap_index.xml)